Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,872,026
in 8 filings, $10.6M under 10b5-1 plans

Net −$32,872,026. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-05-17 Fridriksdottir Hafrun Executive VP, Global R&D Sale −130,000 $8.22 $1.1M 1,386.51
2022-03-07 Fridriksdottir Hafrun Executive VP, Global R&D Sale −8,941 $7.37 $66K 126,086.51
2022-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +23,764 135,027.51
2022-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion · Restricted Share Units −23,764 71,293
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +51,488 116,996.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −18,020 $7.48 $135K 98,976.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +18,905 117,881.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −6,618 $7.48 $50K 111,263.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion · Restricted Share Units −51,488 0
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion · Restricted Share Units −18,905 18,906
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +140,750 140,750
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +21,682 73,098.51
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Sale −7,590 $8.14 $62K 65,508.51
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion · Restricted Share Units −21,682 43,366
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +16,121 57,532.51
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Sale −6,116 $9.06 $55K 51,416.51
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion · Restricted Share Units −16,121 0
2022-02-08 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +51,488 51,488
2021-08-10 Fridriksdottir Hafrun Executive VP, Global R&D Sale −50,860 $9.95 $506K 41,411.51
2021-05-11 Fridriksdottir Hafrun Executive VP, Global R&D Exercise or conversion +37,884 111,337.51

Page 1 of 5 · 95 trades